Commentary on "Developing a national strategy to prevent dementia: Leon Thal Symposium 2009." The rationale for a National Institutional Review Board for neurodegenerative diseases.
Snyder
Peter J
PJ
Department of Neurology, Alpert Medical School of Brown University, Providence, RI, USA. psnyder@lifespan.org
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control*; D026661:Clinical Trials Data Monitoring Committees / Q000592:standards*; D002986:Clinical Trials as Topic / Q000941:ethics* / Q000592:standards*; D028744:Ethics Committees, Research / Q000592:standards*; D004992:Ethics, Medical; D006291:Health Policy / Q000331:legislation & jurisprudence*; D006801:Humans; D007258:Informed Consent; D019636:Neurodegenerative Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000517:prevention & control*; D018579:Patient Selection; D012107:Research Design